Clinical Trial Update: Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe Asthma

View source ↗

Summary

An investigation evaluating the correlation between IgE parameters and response to omalizumab in subjects with severe asthma has been withdrawn from ClinicalTri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Carmel Medical Center | Conditions: Severe Allergic Asthma | Status: WITHDRAWN